MedTrace Logo

STELLA-FTD: Examination of a Behavior Change Intervention for FTD Family Care Partners

NCT06613204 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 640

Last updated 2025-10-27

No results posted yet for this study

Summary

The purpose of this nationwide study is to test STELLA-FTD (Support via Telehealth: Living and Learning with Advancing Alzheimer's Disease)-FTD, an intervention to specifically address the needs of family Care Partners of persons with frontotemporal degeneration (FTD). STELLA-FTD is a multicomponent videoconference-based intervention designed to facilitate effective use of community and peer resources to foster effective management of behavioral and psychological symptoms of dementia. The study is recruiting families from across the United States.

Conditions

  • Frontotemporal Dementia
  • Caregiver Burden
  • Primary Progressive Aphasia (PPA)
  • Corticobasal Syndrome

Interventions

BEHAVIORAL

STELLA-FTD Control

Participants receive information about FTD and support via weekly group video-conference-based meetings.

BEHAVIORAL

STELLA-FTD Test

The test group receives a information and support, but with a focus that is different from the Control Group

Sponsors & Collaborators

  • National Institute on Aging (NIA)

    collaborator NIH

  • Oregon Health and Science University

    lead OTHER

Principal Investigators

  • Allison Lindauer, PhD, APRN · Oregon Health and Science University

  • Aimee Mooney, MA, CCC-SLP · Oregon Health and Science University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-06-23
Primary Completion
2029-06-30
Completion
2029-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06613204 on ClinicalTrials.gov